These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. Corbett TH; Roberts BJ; Trader MW; Laster WR; Griswold DP; Schabel FM Cancer Treat Rep; 1982 May; 66(5):1187-200. PubMed ID: 7083221 [TBL] [Abstract][Full Text] [Related]
29. Testing therapeutic potency of anticancer drugs in animal studies: a commentary. Den Otter W; Steerenberg PA; Van der Laan JW Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):266-72. PubMed ID: 12052010 [TBL] [Abstract][Full Text] [Related]
30. Rationale for the use of alternating non-cross-resistant chemotherapy. Goldie JH; Coldman AJ; Gudauskas GA Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033 [No Abstract] [Full Text] [Related]
31. [Experimental methodology for the selection of potential anticancer agents]. Pérez Mínguez F; Llombart Bosch A Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364 [TBL] [Abstract][Full Text] [Related]
32. Statistical designs for experiments in combination therapy. Miller I Cancer Chemother Rep 2; 1974 Mar; 4(1):151-6. PubMed ID: 4826494 [No Abstract] [Full Text] [Related]
33. G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors. Leonetti C; Scarsella M; Riggio G; Rizzo A; Salvati E; D'Incalci M; Staszewsky L; Frapolli R; Stevens MF; Stoppacciaro A; Mottolese M; Antoniani B; Gilson E; Zupi G; Biroccio A Clin Cancer Res; 2008 Nov; 14(22):7284-91. PubMed ID: 19010844 [TBL] [Abstract][Full Text] [Related]
34. Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer. Gomez GG; Hutchison RB; Kruse CA Cancer Treat Rev; 2001 Dec; 27(6):375-402. PubMed ID: 11908930 [TBL] [Abstract][Full Text] [Related]
36. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)]. Nowak C; Arnold W; Henneberger G; Tanneberger S Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818 [TBL] [Abstract][Full Text] [Related]
37. Effect of 6-azauridine on plasma cell tumors of mice: correlation of antitumor effect with inhibition of orotic acid metabolism. Conn HO; Creasey WA; Calabresi P Cancer Res; 1967 Apr; 27(4):618-25. PubMed ID: 6071670 [No Abstract] [Full Text] [Related]